Anthony Fauci, MD, Director of the NIH’s National Institute of Allergy and Infectious Diseases (NIAID), offered hope to the thousands of people with confirmed cases of COVID-19, and the millions around the world whose lives have been disrupted by the pandemic caused by SARS-CoV-2, when he expressed to a congressional panel [recently] his hope that the first patients would be dosed with vaccines in development for the novel coronavirus “in a few weeks.”
…
Despite that welcome development, it may take a while before vaccines and other treatments for COVID-19 reach patients who desperately need them.
…
Share this article
Those companies, and dozens of other drug developers and research institutions, are behind the 60 active drug development programs in North America, Europe, and China that are highlighted by GEN in this updated A-List. More than two dozen of these treatments have emerged or been made public just in the two weeks since GEN published its original A-List summarizing COVID-19 therapies in the works, How to Conquer Coronavirus: Top 35 Treatments in Development.
Each prospective treatment is listed in alphabetical order by its developer(s), followed by the treatment name or description, the type of treatment including its mechanism, and a brief status update summarizing recent developments.
